Parvizi Josef 4
4 · Ceribell, Inc. · Filed Feb 23, 2026
Research Summary
AI-generated summary of this filing
Ceribell (CBLL) Director Josef Parvizi Sells 16,714 Shares
What Happened
Director Josef Parvizi sold 16,714 shares of Ceribell (CBLL) on February 19, 2026. The weighted average sale price was $20.27 per share, generating proceeds of approximately $338,793. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.77.
Key Details
- Transaction date: 2026-02-19; Form 4 filed 2026-02-23 (timely filing).
- Type: Sale (S) — open‑market/private sales executed in multiple trades.
- Shares sold: 16,714; weighted average price: $20.27; total proceeds: ~$338,793.
- Price range: $20.00 to $20.77; reporting person can provide a breakdown of quantities at each price on request (per footnote).
- Notable footnotes: transaction executed under a Rule 10b5‑1 trading plan adopted Aug 18, 2025 (F1); reporting person is sole trustee of the Josef Parvizi Trust and co‑trustee of two other trusts and disclaims beneficial ownership except to the extent of pecuniary interest (F2–F6).
- Shares owned after transaction: not specified in the provided filing excerpt.
Context
This was a sale via a pre‑arranged 10b5‑1 plan, which is commonly used to schedule trades and can reduce concerns about opportunistic insider timing. Sales are routine and less indicative of forward guidance than purchases; no options exercise, gift, or tax‑withholding event is reported here.
Insider Transaction Report
Form 4
Ceribell, Inc.CBLL
Parvizi Josef
Director
Transactions
- Sale
Common Stock
[F1][F4][F2][F3]2026-02-19$20.27/sh−16,714$338,793→ 722,652 total(indirect: By Trust)
Holdings
- 907,911(indirect: By Trust)
Common Stock
[F3][F5] - 369,088(indirect: By Trust)
Common Stock
[F3][F6]
Footnotes (6)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025.
- [F2]The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities.
- [F3]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20 to $20.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
- [F5]The Reporting Person is a co-trustee of the Innovation ACP Trust, and therefore may be deemed to share beneficial ownership of these securities.
- [F6]The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
Signature
/s/ Louisa Daniels, Attorney-in-Fact for Josef Parvizi|2026-02-23